Abstract
The purposes of the current review are to (1) define multidisciplinary care and a proposed composition for a multidisciplinary team and (2) summarize process and outcome measures associated with multidisciplinary care for patients with hepatocellular carcinoma (HCC). There has been a shift from multidisciplinary tumor boards to multidisciplinary clinics, which facilitates greater provider discussion and interaction over patients’ treatment course. Although most studies examining the effect of multidisciplinary care for the management of a newly diagnosed patient with HCC rely on surrogate measures of quality cancer care, recent studies have demonstrated significant improvement of stage-stratified survival. HCC is a complex and heterogeneous disease due to the concomitant presence of underlying liver disease and cancer. Given the variety of available treatment options and data showing improved outcomes, it should be considered best practice for HCC patients to be managed by a multidisciplinary team.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
